A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 152 participants.
Also called NCT01611883
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 152 participants
- Sponsor
- Registry
-
NCT01611883
-
- Main results
- A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01611883. Randomized; double masking; primary purpose treatment. Start 2012-07-02 (actual); primary completion 2014-01-16 (actual). Results posted on 2014-12-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Ezetimibe
- Intervention (Drug)
- Placebo
- Lead sponsor
- Organon and Co
Record details
- Record id
cardio:ct-nct01611883- Content hash
1f9c57c746da20be2403868e0ef90f01ae20ff8b11b10d3f02c4189fe1aed8f4